|Bid||234.34 x 800|
|Ask||234.57 x 900|
|Day's range||231.13 - 236.09|
|52-week range||188.10 - 255.93|
|Beta (5Y monthly)||0.66|
|PE ratio (TTM)||94.69|
|Earnings date||08 Aug 2022 - 12 Aug 2022|
|Forward dividend & yield||1.72 (0.75%)|
|Ex-dividend date||13 Jun 2022|
|1y target est||263.80|
Investors are optimistic about STERIS (STE) due to its strong fiscal fourth-quarter results.
Robust performances across all four reporting segments drive STERIS' (STE) fiscal fourth-quarter revenues.
Fourth quarter revenue increases 39% as reported; 11% constant currency organicAs reported EPS of $0.52; adjusted EPS of $2.04Company provides FY23 outlook DUBLIN, IRELAND, May 11, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 fourth quarter ended March 31, 2022. Revenue as reported for the quarter increased 39% to $1.2 billion compared with $873.5 million in the fourth quarter of fiscal 2021. Constant currency o